FDA Recalls Finder

FDA Announces New Safety Plan for Agents Used to Treat Chemotherapy-Related Anemia
16 February 2010, 11:21 am

The U.S. Food and Drug Administration today approved a risk management program to inform healthcare providers and their patients about the risks of a class of drugs called Erythropoiesis-Stimulating Agents (ESAs). For patients with cancer, the program is also designed to help ensure the appropriate administration of these drugs, which they receive to treat anemia that can occur as a result of chemotherapy.

Source: Food and Drug Administration--Press Releases